ResearcherUniversity of PittsburghActive in the last 2 years
Jingjing Sun
Matched on ORCID iD 0000-0002-6230-1015; OpenAlex author ID A5101759529; NIH RePORTER profile ID 14883393. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 1
- Labs led
- 2
- Collaborators
- 5
2020: 1 paper · 2021: none · 2022: 1 grant · 2023: 1 paper · 2024: none · 2025: 2 papers
Papers 4
- Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer. Last author DOI 10.1016/j.smaim.2025.09.003↗
- Modulating immune cells within pancreatic ductal adenocarcinoma via nanomedicine. Last author DOI 10.1042/ebc20243001↗
- Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier. Last author DOI 10.1016/j.mattod.2022.11.008↗
- Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. Co-author DOI 10.1016/j.actbio.2020.01.039↗
Grants 1
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ying Li · 2 shared papers, 2025 · strength 0.71
- Junyi Lin · 2 shared papers, 2025 · strength 0.71
- Narayani Prasad Kar · 1 shared paper, 2025 · strength 0.28
- Song Li · 2 shared papers, 2020–2023 · strength 0.26
- Paper Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-ba… DOI 10.1016/j.mattod.2022.11.008↗
- Paper Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. DOI 10.1016/j.actbio.2020.01.039↗
- Zhuoya Wan · 2 shared papers, 2020–2023 · strength 0.26
- Paper Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-ba… DOI 10.1016/j.mattod.2022.11.008↗
- Paper Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy. DOI 10.1016/j.actbio.2020.01.039↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.